Unique ID issued by UMIN | UMIN000024367 |
---|---|
Receipt number | R000028048 |
Scientific Title | Evaluation of efficacy in diabetes control of basal insulin plus SGLT-2 inhibitor/GLP-1 receptor agonist/ rapid insulin in patients with type 2 diabetes |
Date of disclosure of the study information | 2016/10/12 |
Last modified on | 2021/04/17 12:11:52 |
Evaluation of efficacy in diabetes control of basal insulin plus SGLT-2 inhibitor/GLP-1 receptor agonist/ rapid insulin in patients with type 2 diabetes
Evaluation of efficacy in diabetes control of basal insulin plus SGLT-2 inhibitor/GLP-1 receptor agonist/ rapid insulin
Evaluation of efficacy in diabetes control of basal insulin plus SGLT-2 inhibitor/GLP-1 receptor agonist/ rapid insulin in patients with type 2 diabetes
Evaluation of efficacy in diabetes control of basal insulin plus SGLT-2 inhibitor/GLP-1 receptor agonist/ rapid insulin
Japan |
Type 2 diabetes
Endocrinology and Metabolism |
Others
NO
To evaluate the efficacy and safety of basal insulin plus SGLT-2 inhibitor/GLP-1 receptor agonist/ rapid insulin
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Change in HbA1c after 52 weeks
Change in weight after 52 weeks
Level of self-monitoring of blood glucose
Frequency of hypoglycemia
Change in amount of insulin
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
3
Treatment
Medicine |
Basal insulin plus SGLT-2 inhibitor(52 weeks)
Basal insulin plus GLP-1 receptor agonist (52 weeks)
Basal insulin plus rapid insulin (52 weeks)
20 | years-old | <= |
75 | years-old | > |
Male and Female
1. Participants with type 2 diabetes
2. Participants who can perform self-monitoring blood glucose
3. BMI<=45 kg/m2
4. HbA1c between 7.0 to 10.5 %
1.Participants with severe liver dysfunction
2.Participants with severe renal dysfunction
3.Participants with severe diabetic complications
4.Participants who are pregnant, hope to be pregnant, or are in lactation period
5.Participants whose fasting serum C-peptide immunoreactivity below 0.5ng/ml
6.Participants whose postprandial serum C-peptide immunoreactivity below 0.5ng/ml
75
1st name | Tetsuya |
Middle name | |
Last name | Babazono |
Tokyo Women's Medical University Hospital
Diabetes center
1628666
8-1, Kawadacho, Shinjuku-ku, Tokyo
03-3353-8111
babazono.dmc@twmu.ac.jp
1st name | Junko |
Middle name | |
Last name | Oya |
Tokyo Women's Medical University Hospital
Diabetes center
1628666
8-1, Kawadacho, Shinjuku-ku, Tokyo
03-3353-8111
johya.dmc@twmu.ac.jp
Tokyo Women's Medical University Hospital
none
Self funding
NS building Clinic
Tomonaga Clinic
Tokyo Women's Medical University Hospital
8-1, Kawadacho, Shinjuku-ku, Tokyo
03-3353-8111
krinri.bm@twmu.ac.jp
NO
東京女子医科大学病院(東京都)、NSビルクリニック(東京都)、ともながクリニック(東京都)
2016 | Year | 10 | Month | 12 | Day |
Unpublished
15
Terminated
2016 | Year | 09 | Month | 28 | Day |
2016 | Year | 09 | Month | 28 | Day |
2016 | Year | 10 | Month | 12 | Day |
2018 | Year | 12 | Month | 01 | Day |
2019 | Year | 11 | Month | 01 | Day |
2021 | Year | 04 | Month | 17 | Day |
2021 | Year | 04 | Month | 17 | Day |
2016 | Year | 10 | Month | 11 | Day |
2021 | Year | 04 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028048
Research Plan | |
---|---|
Registered date | File name |
2021/04/17 | 計画書160822.doc |
Research case data specifications | |
---|---|
Registered date | File name |
2021/04/17 | 計画書160822.doc |
Research case data | |
---|---|
Registered date | File name |
2021/04/17 | 計画書160822.doc |
Value
https://center6.umin.ac.jp/ice/28048